The WBENC Certification stands as a nationally respected mark of quality, opportunity, and principled leadership among women-owned businesses. Its emphasis on rigor, integrity, and advancement reflects the same values that guide our work and our relationships every day.

Our Track Record

The scale and impact of our work — across transactions, compliance, and client relationships worldwide.

$3B+

Deals Negotiated in a Single Year (2023)

$500M+

Average Annual Transaction Volume

10,000+

Contracts Advised Across Regulated Industries

$282M+

PBM Savings Secured for Clients

30+

Countries of active legal engagement across healthcare and technology

5

Continents served — North America, Europe, Asia, South America, Africa

165M+

Customer relationships impacted by Robyn Marino’s transaction portfolio

$5B+

Annual global contract portfolio managed at Cigna by Robyn Marino

$7B+

Health plan revenue overseen by Daniel Santos as Chief Legal Officer

010

$1.5B+

Payer-provider M&A transactions advised by Daniel Santos as outside counsel

Ready to Work With a Team That Thinks Like You Do?

Let’s talk about how Global Link Law® can become your strategic legal and compliance advantage.

Why Partner With Global Link Law®

In-House Perspective

Our attorneys held C-suite roles inside Fortune 15 companies and $7B+ health plans. We know what leadership needs — and deliver it every time.

Business-First Legal Strategy

Every solution advances business objectives, not just resolves legal issues. Our work is actionable by design.

Healthcare Industry Depth

Deep specialized expertise in health plans, health technology, pharmacy, insurance, digital health, and regulated data environments.

Cross-Border Transaction Expertise

Proven in structuring and negotiating deals across 30+ countries under multiple regulatory regimes simultaneously.

Trusted Advisor to Leadership

We work directly with CEOs, CFOs, and boards — aligning legal strategy with enterprise priorities and growth objectives.

Integrated Legal & Compliance

One team covers legal, regulatory, and compliance — no gaps between advisors, no missed connections, no conflicting guidance.

Efficient & Transparent

Flat-fee and monthly structures deliver complete budget certainty. Our focus is always your outcome, not billable hours.

Long-Term Partnership Focus

Clients rely on us year after year — across transactions, partnerships, regulatory changes, and new market expansions.

Strategic Legal Counsel for Healthcare & Health Technology

Your organization faces legal and regulatory complexity that demands more than outside counsel — it demands a partner who has sat on your side of the table.

From government investigations and FCPA matters to healthcare M&A and payer contracting, we’ve handled it from the inside and from the courtroom.

Whether you need fractional leadership, transactional support, or a defensible compliance framework, we deliver counsel built around what the business actually needs. What sets us apart is real-world in-house experience — our partners have served in senior legal roles within large and publicly traded companies, giving them a direct understanding of what business leaders and boards actually need from legal counsel.

Book a discovery call now

Issue #4 — Wells Fargo and the Number That Ate the Bank

By Kevin Brenner | Friday, June 12, 2026 Not Good is not an indictment of the companies it…

Issue #3 — Theranos: The Board That Was Built Not To Ask

Theranos had one of the most prestigious boards in America, and one of the least effective. A study of how the board’s missing oversight enabled the fraud, and what it teaches about building boards that verify rather than vouch.

The Rise of the “Fractional Specialist”: Why Legal Teams Are Quietly Rewriting Their Hiring Playbook

By: Daniel Santos, Special Counsel | May 29, 2026 Daniel Santos Helping Healthtech CEOs &…

Not Good: Bad Acts, BIG Costs Issue #2 — Dieselgate: Ten Monkeys, One Beetle, and Cartoons

In Issue #2 of Not Good, Kevin Brenner examines Dieselgate — how Volkswagen’s defeat-device software, an industry-funded monkey exhaust study, and years of concealment from regulators produced over $25 billion in penalties, multiple prison sentences, and a lasting lesson in what happens when compliance risk becomes personal risk.

The New Board Question: “What’s Our Exposure to AI‑Driven Misconduct?”

Two companies, same AI tools, totally different risk profiles. Daniel Santos on the new board question — “What’s our exposure to AI-driven misconduct?” — and why AI accountability, not technology, decides whether your governance holds up under scrutiny.

Red Flag: The Vendor Requested Far More PHI Than the Service Required

A vendor deal that looked routine — clean MSA, sensible pricing, BAA already in place — almost moved forward in minutes. Then the SOW revealed a PHI request far beyond what was actually needed. Robyn D. Marino on why HIPAA compliance doesn’t stop at the BAA, and how SOW-level review changes the risk calculus on healthcare vendor agreements.

Why Global Link Law

Our Track Record

$3B+

$500M+

10,000+

$282M+

30+

5

165M+

$5B+

$7B+

$1.5B+

Ready to Work With a Team That Thinks Like You Do?

Why Partner With Global Link Law®

In-House Perspective

Business-First Legal Strategy

Healthcare Industry Depth

Cross-Border Transaction Expertise

Trusted Advisor to Leadership

Integrated Legal & Compliance

Efficient & Transparent

Long-Term Partnership Focus

Strategic Legal Counsel for Healthcare & Health Technology

Issue #4 — Wells Fargo and the Number That Ate the Bank

Issue #3 — Theranos: The Board That Was Built Not To Ask

The Rise of the “Fractional Specialist”: Why Legal Teams Are Quietly Rewriting Their Hiring Playbook

Not Good: Bad Acts, BIG Costs Issue #2 — Dieselgate: Ten Monkeys, One Beetle, and Cartoons

The New Board Question: “What’s Our Exposure to AI‑Driven Misconduct?”

Red Flag: The Vendor Requested Far More PHI Than the Service Required

“When home.” How a two-word email subject line became part of a $650 million federal case.

Do we still need to care about the FCPA?

Issue #4 — Wells Fargo and the Number That Ate the Bank

Issue #3 — Theranos: The Board That Was Built Not To Ask

The Rise of the “Fractional Specialist”: Why Legal Teams Are Quietly Rewriting Their Hiring Playbook

Not Good: Bad Acts, BIG Costs Issue #2 — Dieselgate: Ten Monkeys, One Beetle, and Cartoons

The New Board Question: “What’s Our Exposure to AI‑Driven Misconduct?”

Red Flag: The Vendor Requested Far More PHI Than the Service Required

“When home.” How a two-word email subject line became part of a $650 million federal case.

Do we still need to care about the FCPA?